FTSE Russell Shire (0422L)
December 19 2018 - 1:30PM
UK Regulatory
TIDMSHP TIDMHIK TIDMAPAX
RNS Number : 0422L
FTSE Russell
19 December 2018
Further to the FTSE notice released on 18 December 2018 in relation to Takeda Pharmaceutical
(Japan): Acquisition of Shire (UK), please note the replacement within the fixed index.
All other details remain unchanged. Please see updated notice below:
Takeda Pharmaceutical (Japan): Acquisition of Shire (UK)
Changes in FTSE UK Index Series
19 December 2018
Further to the FTSE Russell notice published on 14 December 2018, in relation to the acquisition
of Shire (UK, constituent) by Takeda Pharmaceutical (Japan, non-constituent), please see details
of affected indexes and effective dates below:
Shire (UK, B2QKY05) will be deleted from the FTSE 100 index.
Hikma Pharmaceuticals (UK, B0LCW08) will be added to the FTSE 100 Index and removed from the
FTSE 250 Index.
Apax Global Alpha (UK, BWWYMV8) will be added to the FTSE 250 index.
All changes effective from 24 December 2018.
Full Index changes details available on FTSE Russell website.
For further information please contact FTSE Russell Client Services at info@ftserussell.com
or call: Australia +1800 653 680
Hong Kong +852 2164 3333
Japan +81 3 4563 6346
London +44 (0) 20 7866 1810
New York +1866 551 0617
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright (c) 2018 FTSE Russell
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FTSGMMMZRLRGRZM
(END) Dow Jones Newswires
December 19, 2018 13:30 ET (18:30 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024